stem cell research

Dear Research Advocate: The party conventions mark the official start to the general election. In Cleveland we heard rousing daily themes of “Make America (aspirational word) Again”. I kept hoping for “healthy” or “innovative,” aspirations we know rank high with Americans, but that was not to be. Nor -- at least as of this writing -- have any speakers addressed medical progress. Even so, the official Republican platform recognizes the importance of medical research and innovation for our economy and for patients. The Democratic platform , which will be adopted at the DNC convention next week, in fact makes similar points. We’ll see if research and innovation make it into the convention...
blood cancer The University of Colorado’€™s Gates Center for Regenerative Medicine and Stem Cell Biology just announced a potentially game-changing discovery in stem cell research for blood cancers and a whole host of other diseases. Yosef Refaeli and his research team have found a way to expand blood stem cells. This is big news because blood stem cells can help treat blood cancers like leukemia and lymphoma as well as inborn immunodeficiency diseases such as sickle-cell anemia and autoimmune diseases like multiple sclerosis. But up until now, treatment using blood stem cells has been limited by the number of cells a patient can produce. Hundreds of thousands of Americans could be affected...
Dear Research Advocate, With all the conversation about the debt ceiling and tax and entitlement reform, it may surprise you to know that an additional topic is on many minds. A wide majority of Americans, 72%, say the new Congress and the president should take action to expand medical research within the first 100 days of the new legislative session. See this and more in America Speaks , Volume 13, a compilation of national poll data providing insights into public sentiment on key research-related issues. See our press release and download the full Poll Data Summary . These polling results are designed to be used in your advocacy and outreach! Among the growing number of issues that need...
January 9, 2013 The U.S. Supreme Court’s dismissal of Sherley v. Sebelius , a case intended to block federal funding for scientists conducting embryonic stem cell research, is a victory for patients and the research community. This key decision will allow the continuation of federal funding from the National Institutes of Health, providing essential support for scientists to conduct lifesaving research. Embryonic stem cells, which can repair or replace damaged tissue and organs, have advanced research aimed at finding cures and therapies to treat a wide variety of diseases and disorders including vision impairment, spinal cord injuries, and multiple sclerosis. Clinical trials have also...
We extend our deepest condolences to Senator Arlen Specter’s family, friends and colleagues as they mourn the passing of a loved and respected statesman and a true champion of medical research. Specter’s leadership in generating critical support for medical and health research is a testament to his dedication to improving the health of all Americans and securing our position as a global leader in science and innovation. As a congressional leader, Specter played a pivotal role in the doubling of the National Institutes of Health (NIH) budget over five years and two Administrations and in 2009 assured that funding for the NIH and other health agencies were included in the American Recovery...
Diane Rehm; John F. Crowley ; Dr. John Mendelsohn; Dr. Mark Rosenberg; and California Institute for Regenerative Medicine to Receive 2013 Research!America Advocacy Awards WASHINGTON-October 2, 2012 - Research!America’s 17 th annual Advocacy Awards will convene leaders from government, academia, industry and health advocacy organizations to honor leading medical and health research advocates of our time. The event will take place on the evening of Wednesday, March 13, 2013, at the Andrew W. Mellon Auditorium in Washington, DC. The 2013 Advocacy Award winners are Diane Rehm, author and host of WAMU 88.5 and NPR’s “The Diane Rehm Show;” John F. Crowley, patient advocate and inspirational...
Dear Research Advocate, In last week’€™s letter, I highlighted research-related themes in the Republican National Platform. The good news included explicit support for basic and applied research and a pledge to make the R&D tax credit permanent. The bad news included strident criticism of FDA ’€” such that support for adequate funding was unclear ’€” and opposition to embryonic stem cell research. The Democratic platform asserts that Democrats will ’€œdouble funding for key basic research agencies.’€ It also goes further than the Republican platform in improving the research and development tax credit and places a very strong emphasis on science education as critical to our innovation...
Dear Research Advocate, As you know, the Republican Party Platform was unveiled Tuesday during the convention in Tampa. There are direct references to medical and health research and other statements that ’€” if not explicit ’€” definitely imply the need for such research. We can draw from both to enhance our advocacy efforts. The following exemplifies the direct and indirect nature of the platform’€™s embrace of medical and health research: ’€œWe support federal investment in health care delivery systems and solutions creating innovative means to provide greater, more cost-effective access to high quality health care. We also support federal investment in basic and applied biomedical...
Dear Research Advocate, With Rep. Paul Ryan joining the Romney ticket, health is back on the national agenda. Partisan politics aside, this conversation is overdue, since health is indeed an issue that will make or bankrupt us. Research has always figured prominently in the wellbeing of Americans and America ’€“ research brought an end to the polio epidemic, which could have bankrupted the nation in the 1950s, and research is the only answer to the scourge of Alzheimer’€™s that threatens health, quality of life and our national checkbook today. And that is just a starting point for the conversation I hope you are having with everyone who wants to talk about the election. Take the...

Sidebar Quote

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco